World Journal of Gastrointestinal Pharmacology and Therapeutics

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7712)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-8) series, Tables (1-5) series.

Item

Count

PDF

152

WORD

HTML

4455

Figures (1-8)

424

Tables (1-5)

468

Sum=5504

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

236

Download

992

Sum=1228

Publishing Process of This Article

Item

Count

Browse

105

Download

656

Sum=761

May 28, 2024 (publication date) through Sep 19, 2025

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pharmacology and Therapeutics

ISSN

2150-5349

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Talbodec N, Le Roy P, Fournier P, Lesage B, Lepoutre E, Castex F, Godchaux JM, Vandeville L, Bismuth B, Lesage X, Bayart P, Genin M, Rousseaux C, Maquet V, Modica S, Desreumaux P, Valibouze C. Efficacy and tolerability of chitin-glucan combined with simethicone (GASTRAP^® DIRECT) in irritable bowel syndrome: A prospective, open-label, multicenter study. World J Gastrointest Pharmacol Ther 2024; 15(3): 90757 [PMID: 38846967 DOI: 10.4292/wjgpt.v15.i3.90757]
URL:	https://www.wjgnet.com/2150-5349/full/v15/i3/90757.htm

For:

Talbodec N, Le Roy P, Fournier P, Lesage B, Lepoutre E, Castex F, Godchaux JM, Vandeville L, Bismuth B, Lesage X, Bayart P, Genin M, Rousseaux C, Maquet V, Modica S, Desreumaux P, Valibouze C. Efficacy and tolerability of chitin-glucan combined with simethicone (GASTRAP^® DIRECT) in irritable bowel syndrome: A prospective, open-label, multicenter study. World J Gastrointest Pharmacol Ther 2024; 15(3): 90757 [PMID: 38846967 DOI: 10.4292/wjgpt.v15.i3.90757]

URL:

https://www.wjgnet.com/2150-5349/full/v15/i3/90757.htm

Number	Citing Articles
1	Veronique Traynard. Adjunct Therapies to Standard Care for IBS and IBD Patients: Digestive Symptoms Improvement and Quality of Life Optimization. Nutrients 2024; 16(22): 3927 doi: 10.3390/nu16223927
2	Alexandra Adorno Vita, Shihning Teo, Christine Murphy, Afsana Mim Khandaker, Rania A. Hart, Paul Mathews, John W. Wilson, Jacqueline Chaparro, Thomas Aquilino, Isaac Dinsmore, Yuren Wei, Valerie J. Stull, Tiffany L. Weir. Safety, tolerability, and preliminary effects of cricket chitin for adults with IBS: a double-blind randomized crossover pilot trial. Food & Function 2025; 16(18): 7434 doi: 10.1039/D5FO01540E